Comorbidities of HIV/AIDS and the Role of Artificial Intelligence in Treatment, Prevention, and Education

Review Article

Comorbidities of HIV/AIDS and the Role of Artificial Intelligence in Treatment, Prevention, and Education

Uchechukwu Promise Ahanonu ^1*
Feyisara Lawal Abati ²

1 MPH Public Health Researcher Chicago, Illinois, United States.

2 MPH Environmental Health Specialist Peoria, Illinois, United States.

*Corresponding Author: Uchechukwu Promise Ahanonu, MPH Public Health Researcher Chicago, Illinois, United States.

Citation: Uchechukwu P. Ahanonu, Feyisara L. Abati. (2025). Comorbidities of HIV/AIDS and the Role of Artificial Intelligence in Treatment, Prevention, and Education, Journal of BioMed Research and Reports, BioRes Scientia Publishers. 8(3):1-3. DOI: 10.59657/2837-4681.brs.25.189

Copyright: © 2025 Uchechukwu Promise Ahanonu, this is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Received: July 01, 2025 | Accepted: July 14, 2025 | Published: July 21, 2025

Abstract

The HIV/AIDS epidemic continues to affect millions globally, even in the face of remarkable progress in antiretroviral therapy (ART). While ART has significantly improved the life expectancy of people living with HIV (PLWH), the chronic nature of the disease and long-term medication use have led to a growing burden of comorbidities such as cardiovascular disease, cancer, neurocognitive disorders, metabolic complications, and osteoporosis. These comorbidities necessitate more holistic and tailored healthcare strategies. In parallel, artificial intelligence (AI) is revolutionizing the healthcare landscape by offering predictive, personalized, and scalable solutions in disease management. This paper explores the biological and clinical basis of HIV/AIDS-related comorbidities and evaluates the transformative potential of AI in improving treatment adherence, enhancing prevention strategies, and personalizing educational tools. Integrating AI into HIV/AIDS management can significantly enhance outcomes, particularly in resource-limited settings, and offers a glimpse into the future of precision public health.

Keywords: although antiretroviral therapy; artificial intelligence; neurocognitive disorders

Introduction

HIV/AIDS has remained a persistent and complex global public health concern. Although antiretroviral therapy (ART) has revolutionized the care landscape—turning HIV from a fatal disease into a manageable chronic condition—comorbidities now represent a major challenge in the long-term health of people living with HIV (PLWH). These conditions include cardiovascular diseases, certain cancers, neurocognitive disorders, metabolic abnormalities, and bone-related complications, all of which significantly affect quality of life and care complexity.

Emerging digital technologies, particularly artificial intelligence (AI), are offering new tools to support and streamline HIV care. AI applications in healthcare include machine learning (ML), natural language processing (NLP), and data analytics. These innovations are being utilized to optimize treatment, improve prevention outreach, and customize patient and provider education. This paper outlines the interplay between HIV/AIDS comorbidities and AI’s role in managing and transforming HIV healthcare delivery.

Comorbidities of HIV/AIDS

Cardiovascular Diseases (CVD)

People living with HIV are at heightened risk for cardiovascular diseases such as hypertension, myocardial infarction, and stroke. This is due to a complex interplay of chronic immune activation, inflammation, ART-induced lipid abnormalities, and lifestyle factors. Studies show that PLWH have a 50–100% increased risk of cardiovascular events compared to individuals without HIV (Triant, 2013).

Cancers
The risk of developing certain cancers is elevated in PLWH due to HIV-induced immunosuppression. AIDS-defining cancers include Kaposi’s sarcoma, non-Hodgkin lymphoma, and cervical cancer. Additionally, non-AIDS-defining malignancies such as anal, lung, and liver cancer are more common in this population. Oncogenic viruses, like human papillomavirus (HPV) and Epstein-Barr virus (EBV), tend to have greater oncogenic potential in immunocompromised hosts (Shiels et al., 2011).

Neurocognitive Disorders

HIV-associated neurocognitive disorders (HAND) remain prevalent, despite viral suppression with ART. HAND includes a range from mild cognitive impairment to more severe dementia. These disorders are believed to stem from direct viral effects on the brain and ongoing neuroinflammation. Cognitive dysfunction can impair memory, attention, and executive function, leading to decreased adherence and poorer overall outcomes (Heaton et al., 2010).

Metabolic Disorders

ART, particularly regimens that include protease inhibitors, can lead to metabolic complications such as insulin resistance, lipodystrophy, and dyslipidemia. These issues elevate the risk of developing type 2 diabetes and metabolic syndrome. Lifestyle factors, aging, and chronic inflammation also contribute significantly to these risks (Riddler et al., 2003).

Osteoporosis

Reduced bone mineral density is more common in PLWH than in the general population. Chronic inflammation, vitamin D deficiency, ART toxicity (especially tenofovir disoproxil fumarate), and low body weight contribute to this problem. Osteoporosis increases the risk of fractures and long-term disability (Brown & Qaqish, 2006).

The Role of Artificial Intelligence in HIV/AIDS Management

Artificial intelligence is transforming modern healthcare through the power of data-driven decision-making and automation. In HIV/AIDS care, AI tools are enhancing clinical decision-making, optimizing resource allocation, and tailoring interventions based on individual patient profiles.

AI in HIV Treatment

AI applications in HIV treatment include predictive analytics and personalized regimen selection. Machine learning algorithms analyze electronic health records, behavioral data, and socio-demographic profiles to identify patients at risk for non-adherence to ART. This enables providers to intervene early with support strategies. For instance, Esteva et al. (2019) demonstrated the ability of ML models to predict ART adherence with high accuracy.

Additionally, AI can assist clinicians in selecting the most effective ART regimens by integrating data on genetic markers, viral load trends, and historical drug responses. Such precision medicine approaches reduce the risk of adverse effects, prevent resistance, and improve overall treatment outcomes (Wang et al., 2018).

AI in HIV Prevention

Prevention remains a cornerstone in the effort to control HIV transmission. AI is being used to identify populations at heightened risk and guide the distribution of interventions like pre-exposure prophylaxis (PrEP). Predictive modeling can pinpoint geographic regions and social networks most vulnerable to outbreaks. Schneider et al. (2020) used these models to forecast HIV incidence in U.S. counties, enabling more efficient public health responses.

Moreover, AI tools can support PrEP campaigns by identifying individuals who may benefit based on behavioral patterns and environmental data. This level of targeting ensures resources are allocated effectively, particularly in high-risk and underserved communities (Panch et al., 2019).

AI in HIV Education

AI-powered educational tools are bridging knowledge gaps in both patients and healthcare providers. Chatbots and virtual assistants such as Florence offer on-demand information on HIV management, prevention strategies, and medication adherence. These tools are especially beneficial for populations with limited access to in-person health services (Rielly, 2020).

In clinical settings, AI can personalize educational content based on user behavior, language proficiency, and comprehension levels. For healthcare professionals, AI platforms can provide real-time updates on clinical guidelines, drug interactions, and comorbidity management (Jiang et al., 2017).

Conclusion

While ART has significantly improved outcomes for people living with HIV, comorbidities such as cardiovascular disease, cancers, neurocognitive impairments, metabolic disorders, and osteoporosis continue to present complex challenges. These issues necessitate a multidisciplinary approach and innovative solutions.

Artificial intelligence holds great promise in transforming the landscape of HIV/AIDS care. Its ability to harness and interpret vast datasets enables more accurate predictions, targeted interventions, and customized education. Continued investment in AI technology—paired with equitable access and robust ethical frameworks—can enhance the quality of care for PLWH globally, particularly in resource-constrained environments.

References

Brown, T. T., & Qaqish, R. B. (2006). Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: A meta-analytic review. AIDS, 20(17):2165–2174.
Publisher | Google Scholor
Esteva, A., Robicquet, A., Ramsundar, B., et al. (2019). A guide to deep learning in healthcare. Nature Medicine, 25:24–29.
Publisher | Google Scholor
Heaton, R. K., Clifford, D. B., Franklin, D. R., et al. (2010). HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology, 75(23):2087–2096.
Publisher | Google Scholor
Jiang, F., Jiang, Y., Zhi, H., et al. (2017). Artificial intelligence in healthcare: Past, present and future. Stroke and Vascular Neurology, 2(4):230–243.
Publisher | Google Scholor
Panch, T., Mattie, H., & Atun, R. (2019). Artificial intelligence and algorithmic bias: Implications for health systems. Journal of Global Health, 9(2):010318.
Publisher | Google Scholor
Riddler, S. A., Haubrich, R., DiRienzo, A. G., et al. (2003). Class-sparing regimens for initial treatment of HIV-1 infection. The New England Journal of Medicine, 348(3):209–221.
Publisher | Google Scholor
Rielly, A. (2020). Florence: The AI chatbot revolutionizing patient education. Digital Health Journal, 6(1):15–21.
Publisher | Google Scholor
Schneider, J. A., Zhou, A. N., & Laumann, E. O. (2020). A predictive risk model for HIV outbreaks in U.S. counties. PLoS ONE, 15(3):e0226785.
Publisher | Google Scholor
Shiels, M. S., Pfeiffer, R. M., & Gail, M. H. (2011). Cancer burden in the HIV-infected population in the United States. Journal of the National Cancer Institute, 103(9):753–762.
Publisher | Google Scholor
Triant, V. A. (2013). Cardiovascular disease and HIV infection. Current HIV/AIDS Reports, 10(3):199–206.
Publisher | Google Scholor
Wang, S., Summers, R. M., & Barua, S. (2018). Machine learning in medicine: AI solutions for HIV care. Journal of the American Medical Association, 320(22):2347–2348.
Publisher | Google Scholor

Delia Teresa Sponza

"Journal of BioMed Research and Reports has created a diverse portfolio in peer review process and provides a wide range scientific and medical novel papers to the scientists. This journal publishes high-quality, peer-reviewed content across all levels of professional development and corporate research and development."

Fatema Tashrifwala

I would like to thank the editorial team for their timely responses and consideration in the publication of my paper. They have been very helpful and accommodating, Lastly, being an open access journal, the published work is freely available and accessible to readers at no cost to them. I would encourage other authors to publish their research in BioRes Scientia. I am happy to be a part of BioRes Scientia Publishers.

Dr Nikhil Vitthal Dayama

I would like to thank the editorial team for their timely and prompt responses and consideration in the publication of my case report. Being an open access journal, it will be great help for the readers to learn the new things without any cost. I would encourage the authors to publish their research in BioRes Scientia and I am happy to be part of this journal.

Boubacar Ahy Diatta

I warmly thank the editorial team for the excellent work they do for continuing medical education in Dermatology. I was able to discover with joy their professionalist, their support and above all appreciate their social generosity on the access to the magazines which is free. This allows an update of scientific knowledge to the entire scientific community. I gladly recommend authors for publication in this journal.

Professor Rajko Igic

The editor of JBRR helped me during the whole process, mainly to eliminate some typographical and other errors. It hastened this publication to be published quickly. Although it is a short text, I believe that the content is important for all medical and other scientific disciplines because eventual addition of the iC citations to citation of the paper would lead to proper assessment of the author's contribution.

Dr Tewodros kassahun Tarekegn

I am thrilled to have had the opportunity to publish my research article in this prestigious journal. The entire process of peer review and publication support provided by the editorial office was exceptional, and it fortified my belief in the quality of my research study. The rigorous peer review process ensured that only the highest quality research was published, and the feedback from the reviewers was extremely helpful. I appreciate the journal's commitment to open access publication, enabling my research to reach a wider audience. The easy-to-use online platform streamlined the submission, peer review, and publication process, and I would confidently recommend this journal to any author looking for efficient, rigorous, and high-quality peer-reviewed publication.

Francis Okello Ooko

I was impressed by your author-centred approach whereby you maintained constant and timely communication with us from the time we submitted the manuscript to acceptance, each time providing critical suggestions to improve the manuscript. In addition, we are encouraged by the thoroughness of your editorial team in checking the originality and overall, quality of the work. Which I believe is very encouraging to other researchers and authors who wish to publish their work in your journals. The published work and the information imparted is freely available and accessible to a wide spectrum of readers at no cost to them. I would encourage other authors to publish their research in BioRes Scientia. I am happy to be a part of BioRes Scientia Publishers.

Dr Nidhi Sapolia

I would like to thank the editorial team of their timely response and guidance in the publication of my case report. They have been extremely helpful at all stages. Being an open access journal, it is of great help for the readers to learn new experiences in different fields, I would highly recommend this journal to authors for high quality peer-reviewed publications.

Dwight L Mckee MD CNS ABIHM

I am very impressed by the high quality of the papers published by the International Journal of Clinical and Molecular Oncology. The editors of this journal are a pleasure to work with, as they are highly responsive even to numerous last minute changes in the manuscript that I recently published with them, and the changes are made on-line the same day they are received. I highly recommend this journal to anyone working in the oncology field, and also value it as a source of cutting edge information in the field.

Kyaw Swar Thet

I would like to thank the editorial team for the opportunity to publish our case report in this prestigious journal. I am very impressed by their timely and efficient handling of the submission, peer review, and publication processes. As residents of a developing, low-income country, we greatly appreciate the discount on submission charges. I hope that as an open access journal, it will facilitate easy access for readers to update their scientific knowledge. I highly recommend this journal for high-quality, peer-reviewed publications. I express my sincere gratitude to the editorial team for their excellent work.

Michel Farah

I would like to thank the editorial team for their quick response and support. The publication support and editorial office were excellent and very helpful. I am happy to have my research article published in this prestigious journal. Our previous case report published in this journal was very successful and viewed by many physicians worldwide.

Kristina Dimitrijevic

I am very positively surprised by thе International Journal of Biomedical and Clinical Research, as well as by the review process itself, which is carried out in a high-quality, timely and professional manner. I am glad that my articles are part of this journal.

Hamid Kasim

I had the pleasure of working with your esteemed journal. I testify that the peer review process was effective and quick, the support from the editorial office is very professional, respectful and friendly and the quality of the review is objective and accurate. I am grateful for the opportunity to work with International Journal of Biomedical & Clinical Research and looking forward for more future cooperation.

Ochala Ejura J

The interaction with the Journal of Women Health Care and Gynaecology has been seamless. I wish to express my profound appreciation to your expert editorial team for the timely response and support. The feedbacks from the peer review process was of great help. Thank you for the discount and opportunity to publish in your reputable journal. I believe that being an Open access journal, it will enable readers easy access to to update their knowledge. I would recommend BioRes Scientia publishers and look forward to more collaborations.

Fernando M Clara

I would like to thank the Journal of Clinical Cardiology and Cardiology Research for the opportunity to publish our work. We greatly appreciate the professionalism demonstrated throughout the editorial process. The rapid peer review, along with the high-quality graphic design, streamlined the process and significantly improved the final presentation of our manuscript. The Journal’s support for scientific dissemination is a meaningful incentive for ongoing research. We commend your editorial efforts and extend our best wishes for the Journal's continued success.

Dr Stylianos Sergios Chatziioannou

Journal of BioMed Research and Reports process was constructive and timely, ensuring that the scientific rigor of the manuscript was upheld. Communication with the editorial office was smooth and supportive throughout, making the overall publication experience very positive. I appreciate the efforts of the editorial team in maintaining high-quality standards, and I am confident that the journal will continue to grow in impact and recognition.

Dr C Zeroual

I am pleased to have worked with the Journal of Brain Research and Neurology. The editorial team was responsive and supportive throughout the process, and the peer review was handled efficiently. I appreciate the opportunity to contribute to this journal and look forward to future collaborations

Mohammadreza Kashefi Baher

I am pleased to have published my research in Dentistry and Oral Health Care. The peer review process was efficient and respectful, and I appreciated the timely communication and support from the editorial team. The journal maintains a professional standard and provides an accessible platform for sharing scientific work. I am grateful for the opportunity and look forward to contributing again in the future.

Cidalia De Fatima Cabral De Frias

I would like to thank the editorial team of International Journal of Biomedical and Clinical Research for their prompt and timely responses during the review process of my article. I had the opportunity to share with the academic community my understanding of the process of caring for a person at the end of life. I recommend the publication of research in the area of palliative care in this prestigious journal.

Roxana Maria Hoza

The peer review process at Hematology Research and Blood Disorders is fair and constructive. The editorial office provides excellent support and timely communication. The journal maintains high quality and is a trusted platform for hematology research.

Dr Hamid Kasim

I was very pleased to collaborate with your esteemed Journal of BioMed Research and Reports, and I also thank the editorial board and the reviewers who enriched my article with their very helpful comments, resulting in a beautiful and elegant presentation. I hope our collaboration will continue in the future, With my respect and best wishes for your continued success.